R&D JP Morgan 2023 - Stefan Weber and Ravi Anand pharmaphorum sits down with Stefan Weber and Ravi Anand of neurology-focused biotech Newron.
Sales & Marketing Sponsored Investing in healthcare futures: Elia Stupka and Paul Tunnah Angelini Ventures is an new investment fund seeking companies transformational in healthcare.
R&D Optimisation of signal management in pharmacovigilance Signal management is a fundamental aspect of pharmacovigilance, required by regulatory agencies
R&D Sponsored Data security and trust essential for driving data forward i... Pharma brands need to be clear that data initiatives are backed by secure, compliant systems.
R&D JP Morgan 2023 – Claudia Ulbrich Last month, pharmaphorum sat down with Claudia Ulbrich, CEO of Germany-based Cardior.
R&D How connected compliance technology will improve pharmaceuti... Regulatory and compliance issues have weighed down the pharmaceutical environment for decades.
News BridgeBio gains on phase 3 dwarfism data Shares in BridgeBio rose after it revealed data from a trial of infigratinib in achondroplasia, raising the prospect of the first oral treatment.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
